Quantifying the value of personalized medicines : evidence from COX-2 inhibitors
Year of publication: |
2013
|
---|---|
Authors: | Sood, Neeraj ; Philipson, Tomas J. ; Huckfeldt, Peter |
Published in: |
Forum for health economics & policy : an evolving collection of symposia on important health care issues. - Berlin : De Gruyter, ISSN 1558-9544, ZDB-ID 2233218-2. - Vol. 16.2013, 1, p. 101-122
|
Subject: | adverse events | diagnostics | innovation | personalized medicines | social value | Arzneimittel | Pharmaceuticals | Medizinische Behandlung | Medical treatment | Patienten | Patients | Innovation | Soziale Werte | Social values |
Extent: | graph. Darst. |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | Systemvoraussetzungen: Acrobat Reader |
Other identifiers: | 10.1515/fhep-2013-0005 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Atella, Vincenzo, (2017)
-
Bussiere, Clémence, (2022)
-
The impact of tort reform on intensity of treatment : evidence from heart patients
Avraham, Ronen, (2015)
- More ...
-
Price shopping in consumer-directed health plans
Sood, Neeraj, (2013)
-
Effects of payment reform in more versus less competitive markets
Sood, Neeraj, (2015)
-
Effects of payment reform in more versus less competitive markets
Sood, Neeraj, (2017)
- More ...